Glyxambi alternatives?

Glyxambi is a fixed-dose combo of empagliflozin (SGLT2 inhibitor) and linagliptin (DPP-4 inhibitor). Alternatives depend on what you’re looking for (same kind of combo, different components, or a different class). Here are common options by category:

Fixed-dose combos similar to Glyxambi (SGLT2 inhibitor + DPP-4 inhibitor)
- Qtern (dapagliflozin + saxagliptin) – another SGLT2 + DPP-4 fixed-dose option.
- Trijardy XR (empagliflozin + linagliptin + metformin) – a triple therapy that adds metformin.
- Xigduo XR (dapagliflozin + metformin) – SGLT2 + metformin, if you’re open to a metformin-containing two-drug combo.
- Kombiglyze XR (linagliptin + metformin) – DPP-4 inhibitor plus metformin.

Fixed-dose combos with different components (not Glyxambi)
- Combos with metformin layers (common two-drug options): Synjardy (empagliflozin + metformin), Invokamet (canagliflozin + metformin), Xigduo XR (dapagliflozin + metformin), Kombiglyze XR (linagliptin + metformin).
- Other DPP-4 inhibitor combos: Januvia (sitagliptin) and metformin (Janumet); Nesina (alogliptin) with metformin (you’ll check the specific fixed-dose product availability in your country).

Alternatives by drug class (not fixed-dose)
- Other SGLT2 inhibitors you could use as options (sometimes alone or with metformin): dapagliflozin (Farxiga), canagliflozin (Invokana), ertugliflozin (Steglatro), in various single-agent or two-drug combinations.
- Other DPP-4 inhibitors: sitagliptin (Januvia), saxagliptin (Onglyza), alogliptin (Nesina) if you’re considering different DPP-4 options (often as separate tablets or in different combos with metformin).

Non-drug considerations
- If you’re trying to avoid one component (e.g., DPP-4 inhibitors), there are many SGLT2-only or GLP-1 receptor agonist options to discuss with your clinician.
- If you have kidney impairment, note that SGLT2 inhibitors have specific eGFR requirements, and dose adjustments may be needed for metformin-containing combos. DPP-4 inhibitors like linagliptin often don’t require major dose changes for kidney function.

If you’d like, tell me:
- Which components you prefer to keep or avoid (SGLT2 vs DPP-4 vs metformin),
- Your kidney function (eGFR) and any other conditions (heart failure, CKD, etc.),
- Insurance/price considerations,

and I can tailor a short list of suitable alternatives. Also, always check with your prescriber before changing meds.